“Texas Medical Center is synonymous with innovation, and the TMC Innovation space has proven an ideal location for our contract research organization. It’s an important part of our origin story and a big part of our success,” said Kevin Coker, Proxima Clinical Research CEO and co-founder, in a statement.
The medical research company will add nearly 7,500 square feet of office space, according to a news release. The new space will be used for the growing staff and for expanded business services for medical technology customers.
“The continued growth of the life science industry in Houston makes TMC the most appropriate place for Proxima Clinical Research to invest in its future as a company. We look forward to continuing to serve our current and future clients in our new home later this year,” Coker said.
According to the company, Proxima Clinical Research is part of the process that brings medical technology, biotech, pharmaceuticals and devices through the U.S. Food and Drug Administration into the market.